Oppenheimer Asset Management Inc. Ionis Pharmaceuticals Inc Transaction History

Oppenheimer Asset Management Inc.

  • $8.04 Billion
  • Q3 2024

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024
SELL
$36.45 - $47.7 $147,586 - $193,137
-4,049 Reduced 41.21%
5,777 $275,000
Q1 2024

May 06, 2024
SELL
$42.03 - $53.55 $30,387 - $38,716
-723 Reduced 6.85%
9,826 $425,000
Q4 2023

Feb 13, 2024
SELL
$43.39 - $51.63 $18,180 - $21,632
-419 Reduced 3.82%
10,549 $533,000
Q3 2023

Nov 07, 2023
SELL
$38.5 - $47.13 $1,963 - $2,403
-51 Reduced 0.46%
10,968 $497,000
Q2 2023

Aug 02, 2023
SELL
$34.73 - $43.33 $1,250 - $1,559
-36 Reduced 0.33%
11,019 $452,000
Q1 2023

May 10, 2023
BUY
$33.58 - $41.2 $23,035 - $28,263
686 Added 6.62%
11,055 $395,000
Q4 2022

Feb 06, 2023
SELL
$37.12 - $46.52 $17,260 - $21,631
-465 Reduced 4.29%
10,369 $391,000
Q3 2022

Nov 14, 2022
SELL
$36.54 - $48.66 $2,521 - $3,357
-69 Reduced 0.63%
10,834 $479,000
Q2 2022

Aug 08, 2022
SELL
$31.71 - $43.0 $2,917 - $3,956
-92 Reduced 0.84%
10,903 $403,000
Q1 2022

May 12, 2022
BUY
$29.88 - $37.04 $36,244 - $44,929
1,213 Added 12.4%
10,995 $407,000
Q4 2021

Feb 02, 2022
SELL
$25.61 - $35.1 $28,171 - $38,610
-1,100 Reduced 10.11%
9,782 $297,000
Q3 2021

Nov 12, 2021
BUY
$33.54 - $40.55 $5,534 - $6,690
165 Added 1.54%
10,882 $365,000
Q2 2021

Aug 03, 2021
SELL
$34.54 - $47.25 $7,564 - $10,347
-219 Reduced 2.0%
10,717 $427,000
Q1 2021

May 17, 2021
BUY
$42.51 - $63.78 $31,712 - $47,579
746 Added 7.32%
10,936 $491,000
Q4 2020

Feb 11, 2021
SELL
$45.3 - $60.27 $49,195 - $65,453
-1,086 Reduced 9.63%
10,190 $577,000
Q3 2020

Nov 13, 2020
SELL
$47.45 - $62.95 $31,838 - $42,239
-671 Reduced 5.62%
11,276 $535,000
Q2 2020

Aug 11, 2020
SELL
$46.85 - $61.05 $12,930 - $16,849
-276 Reduced 2.26%
11,947 $705,000
Q1 2020

May 08, 2020
SELL
$41.6 - $63.4 $18,304 - $27,896
-440 Reduced 3.47%
12,223 $577,000
Q4 2019

Feb 07, 2020
SELL
$53.85 - $65.27 $16,424 - $19,907
-305 Reduced 2.35%
12,663 $765,000
Q3 2019

Oct 31, 2019
SELL
$59.06 - $72.15 $49,905 - $60,966
-845 Reduced 6.12%
12,968 $777,000
Q2 2019

Aug 09, 2019
SELL
$62.09 - $86.14 $48,864 - $67,792
-787 Reduced 5.39%
13,813 $888,000
Q1 2019

Apr 24, 2019
SELL
$52.92 - $81.17 $10,213 - $15,665
-193 Reduced 1.3%
14,600 $1.19 Million
Q4 2018

Jan 30, 2019
SELL
$43.37 - $59.54 $15,006 - $20,600
-346 Reduced 2.29%
14,793 $800,000
Q3 2018

Oct 26, 2018
SELL
$42.88 - $53.7 $282,793 - $354,151
-6,595 Reduced 30.34%
15,139 $781,000
Q2 2018

Aug 10, 2018
SELL
$40.53 - $50.7 $48,798 - $61,042
-1,204 Reduced 5.25%
21,734 $905,000
Q1 2018

May 09, 2018
BUY
$44.08 - $55.05 $35,440 - $44,260
804 Added 3.63%
22,938 $1.01 Million
Q3 2017

Nov 14, 2017
BUY
$45.56 - $59.57 $1.01 Million - $1.32 Million
22,134
22,134 $1.12 Million

Others Institutions Holding IONS

# of Institutions
403
Shares Held
136M
Call Options Held
862K
Put Options Held
582K
View Full List

About IONIS PHARMACEUTICALS INC

IONS Quotes by TradingView
  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.35B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Oppenheimer Asset Management Inc. Portfolio

Follow Oppenheimer Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email